{
    "id": 26654,
    "fullName": "BAX positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BAX positive indicates the presence of the BAX gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 581,
        "geneSymbol": "BAX",
        "terms": [
            "BAX",
            "BCL2L4"
        ]
    },
    "variant": "positive",
    "createDate": "06/27/2017",
    "updateDate": "08/17/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11298,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CYD-2-11 induced apoptosis in Bax-expressing non-small cell lung cancer cell lines in culture, with cell lines with higher total and phosphorylated Bax expression demonstrating increased sensitivity, and induced apoptosis and inhibited tumor growth in xenograft models (PMID: 28381544).",
            "molecularProfile": {
                "id": 27944,
                "profileName": "BAX positive"
            },
            "therapy": {
                "id": 5927,
                "therapyName": "CYD-2-11",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9215,
                    "pubMedId": 28381544,
                    "title": "Modulation of Bax and mTOR for Cancer Therapeutics.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28381544"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11299,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CYD-2-11 induced apoptosis in Bax-expressing small cell lung cancer (SCLC) cell lines in culture, with cell lines with higher total and phosphorylated Bax expression demonstrating increased sensitivity, and induced apoptosis and inhibited tumor growth in SCLC cell line xenograft and patient-derived xenograft (PDX) models (PMID: 28381544).",
            "molecularProfile": {
                "id": 27944,
                "profileName": "BAX positive"
            },
            "therapy": {
                "id": 5927,
                "therapyName": "CYD-2-11",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9215,
                    "pubMedId": 28381544,
                    "title": "Modulation of Bax and mTOR for Cancer Therapeutics.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28381544"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27944,
            "profileName": "BAX positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}